ABOS
Acumen Pharmaceuticals (ABOS)
$44
About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.
Details
Daily high
$2.44
Daily low
$2.29
Price at open
$2.29
52 Week High
$3.60
52 Week Low
$1.19
Market cap
176.2M
Dividend yield
0.00%
Volume
256,800
Avg. volume
361,955
P/E ratio
-1.31
Acumen Pharmaceuticals News
Details
Daily high
$2.44
Daily low
$2.29
Price at open
$2.29
52 Week High
$3.60
52 Week Low
$1.19
Market cap
176.2M
Dividend yield
0.00%
Volume
256,800
Avg. volume
361,955
P/E ratio
-1.31